Novo Nordisk, in a mixed-bag earnings report, beat expectations on Wegovy sales but tightened its 2024 outlook ...Middle East

Novo Nordisk (NVO) reported mixed earnings for the third quarter of 2024 but beat Wall Street revenue expectations for its blockbuster weight-loss drug, Wegovy. Novo […] The post Novo Nordisk, in a mixed-bag earnings report, beat expectations on Wegovy sales but tightened its 2024 outlook appeared first on Canadian News Today.

Read More Details
Finally We wish PressBee provided you with enough information of ( Novo Nordisk, in a mixed-bag earnings report, beat expectations on Wegovy sales but tightened its 2024 outlook )

Also on site :

• Thunberg accuses Israel of kidnap after Gaza aid boat intercepted
• Diddy trial live: Ex-girlfriend ‘Jane’ describes what happened during sex parties after judge denies mistrial request
• Chart-Topping '90s Rocker, 59, Stuns Fans With Unexpected Side Career